메뉴 건너뛰기




Volumn 32, Issue 3, 2010, Pages 510-511

Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus: Letters to the Editors

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

EID: 77954319605     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04372.x     Document Type: Letter
Times cited : (8)

References (6)
  • 1
    • 77950575872 scopus 로고    scopus 로고
    • Infliximab as rescue medication for patients with severe ulcerativeindeterminate colitis refractory to tacrolimus
    • Herrlinger KR, Barthel DN, Schmidt KJ, et al. Infliximab as rescue medication for patients with severe ulcerativeindeterminate colitis refractory to tacrolimus. Aliment Pharmacol Ther 2010 31:1036 1041.
    • (2010) Aliment Pharmacol Ther , vol.31 , pp. 1036-1041
    • Herrlinger, K.R.1    Barthel, D.N.2    Schmidt, K.J.3
  • 2
    • 77951725509 scopus 로고    scopus 로고
    • Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus
    • Yamamoto S, Nakase H, Matsuura M, et al. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. J Gastroentrol Hepatol 2010 25:886 891.
    • (2010) J Gastroentrol Hepatol , vol.25 , pp. 886-891
    • Yamamoto, S.1    Nakase, H.2    Matsuura, M.3
  • 3
    • 55349146598 scopus 로고    scopus 로고
    • Systematic review: Cytomegalovirus infection in inflammatory bowel disease
    • Nakase H, Matsumura K, Yoshino T, Chiba T. Systematic review: cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 2008 43:735 740.
    • (2008) J Gastroenterol , vol.43 , pp. 735-740
    • Nakase, H.1    Matsumura, K.2    Yoshino, T.3    Chiba, T.4
  • 4
    • 67650252520 scopus 로고    scopus 로고
    • Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis
    • Criscuoli V, Mocciaro F, Orlando A, et al. Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis. Inflamm Bowel Dis 2009 15:810 811.
    • (2009) Inflamm Bowel Dis , vol.15 , pp. 810-811
    • Criscuoli, V.1    Mocciaro, F.2    Orlando, A.3
  • 5
    • 50849096081 scopus 로고    scopus 로고
    • Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNF therapy
    • D' Ovidio V, Vernia P, Gentile G, et al. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNF therapy. J Clin Virol 2008 43:180 183.
    • (2008) J Clin Virol , vol.43 , pp. 180-183
    • Ovidio, V.D.'.1    Vernia, P.2    Gentile, G.3
  • 6
    • 77949500060 scopus 로고    scopus 로고
    • TNF is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: Lesson from clinical experience
    • Nakase H, Chiba T. TNF is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: lesson from clinical experience. Inflamm Bowel Dis 2010 16:550 551.
    • (2010) Inflamm Bowel Dis , vol.16 , pp. 550-551
    • Nakase, H.1    Chiba, T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.